A detailed history of Pro Share Advisors LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 29,237 shares of MRVI stock, worth $141,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,237
Holding current value
$141,799
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.84 - $9.73 $199,981 - $284,476
29,237 New
29,237 $242,000
Q4 2022

Feb 02, 2023

SELL
$12.5 - $24.78 $3,325 - $6,591
-266 Reduced 2.08%
12,538 $179,000
Q3 2022

Nov 04, 2022

BUY
$20.6 - $30.37 $16,171 - $23,840
785 Added 6.53%
12,804 $327,000
Q2 2022

Aug 01, 2022

SELL
$26.05 - $37.48 $106,153 - $152,731
-4,075 Reduced 25.32%
12,019 $342,000
Q1 2022

May 10, 2022

SELL
$24.46 - $40.92 $126,189 - $211,106
-5,159 Reduced 24.27%
16,094 $568,000
Q4 2021

Feb 08, 2022

BUY
$35.0 - $45.94 $743,855 - $976,362
21,253 New
21,253 $891,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $638M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.